Liver Cirrhosis: all 1,668 studies
Page 6 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)CompletedNCT00048724Phase 3Results posted
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)CompletedNCT00039871Phase 3Results posted
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompletedNCT00006164Phase 3Results posted
- Safety of Anticoagulation Therapy in Cirrhotic Patients With PVT and Severe ThrombocytopeniaCompletedNCT07885969
- AI-SC Multi-center StudyActive, not recruitingNCT07885007
- Residual Histological Disease Across Treatment Pathways in Chronic Hepatitis BCompletedNCT07843446
- Effect of LSD on Renal Function in Cirrhotic Patients With Portal HypertensionCompletedNCT07811713
- Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension BleedingCompletedNCT07811700
- Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver CirrhosisCompletedNCT07791940Phase 4
- Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome TypesCompletedNCT07730736
- Assessing EUS and Percutaneous Untargeted Liver Biopsy QualityCompletedNCT07701031
- Deep Learning for Liver Fibrosis Triage in MASLD Using Longitudinal Electronic Health RecordsCompletedNCT07675525
- Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLDCompletedNCT07663682
- Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized PatientsActive, not recruitingNCT07656428
- Patients With Primary Biliary Cholangitis(PBC)Active, not recruitingNCT07629128
- The Effect of a Personalized Protein- and Energy-optimized Diet on Muscle Strength in Adult Patients With Chronic Liver DiseaseCompletedNCT07625085Not applicable
- Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein ThrombosisCompletedNCT07571460Phase 4
- Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and PredictorsActive, not recruitingNCT07560202
- Risk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver DiseaseCompletedNCT07537829
- Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)Active, not recruitingNCT07530419
- Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep ProblemsCompletedNCT07480096Phase 2
- Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver CirrhosisCompletedNCT07459972Phase 4
- Dose Optimization of Sitagliptin and Duloxetine in Diabetic CirrhosisCompletedNCT07439536Phase 4
- Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver CirrhosisActive, not recruitingNCT07437638
- Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic PatientsCompletedNCT07397481Phase 4
- Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy ControlsCompletedNCT07394309Phase 1
- Improving Healthcare Outcomes With Early Detection of Liver Related Complications in Liver Cirrhosis Patients by Implementing a Telemedicine Care Pathway (myLIVERcoach)CompletedNCT07376967Not applicable
- Double Stent for Biliary Stones in Cirrhotic PatientsCompletedNCT07337291Not applicable
- Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver DiseaseCompletedNCT07294963Not applicable
- QTc Assessment in a Single-Dose Study of Hydronidone CapsulesCompletedNCT07263152Phase 1
- The Phase Ⅰd Clinical Trial of Hydronidone CapsulesCompletedNCT07262346Phase 1
- Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsActive, not recruitingNCT07238114
- Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver CirrhosisCompletedNCT07193316
- Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- ThalassemiaCompletedNCT07153926
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary StudyActive, not recruitingNCT07140120
- Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune ResponseTerminatedNCT07102979Not applicable
- The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.CompletedNCT07069725Phase 1
- Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With UltrasoundActive, not recruitingNCT07051369
- A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.CompletedNCT07037394Phase 4
- DELIVER Study in a Population With Clinical Suspicion of Liver CirrhosisCompletedNCT07035158
- Care Algorithm and Clinic Decision System on Hepatic Rehabilitation in Patients With Liver CirrhosisCompletedNCT06995196Not applicable
- A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With QuinidineCompletedNCT06974565Phase 1
- A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy ParticipantsCompletedNCT06973005Phase 1
- Incidence of Liver Disease-Related Outcomes in People With HIVCompletedNCT06940375
- Chronic Liver Disease and Radiation-induced Second Primary Liver MalignancyCompletedNCT06868394
- Endosonographic Shear Wave Elastography to Assess Liver and Splenic FibrosisCompletedNCT06867731
- Validation of New Prognostic Biomarkers in Patients With Decompensated CirrhosisCompletedNCT06855056
- Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical TrialActive, not recruitingNCT06842563
- Colonic Polypectomy in Cirrhotic Patients With Portal HypertensionCompletedNCT06832826
- Comparative Study of Secondary Prophylaxis for SBPCompletedNCT06827756Phase 4
- RTX001 Autologous Engineered Macrophages for Liver CirrhosisActive, not recruitingNCT06823713Phase 1/2
- A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389CompletedNCT06812780Phase 1
- Spirulina Tablets Treat Liver Fibrosis/CirrhosisActive, not recruitingNCT06770283Not applicable
- Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And CirrhosisActive, not recruitingNCT06749522
- Liver Cirrhosis Patients' Digital Health Literacy and Perspective on Digital Healthcare, a Multicenter Questionnaire StudyCompletedNCT06745843Not applicable
- A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese ParticipantsCompletedNCT06715670Phase 1
- To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA CapsulesCompletedNCT06708832Not applicable
- naVIGation Invitations Liver surveillANce upTakeActive, not recruitingNCT06635694
- Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic IndexesTerminatedNCT06630572Phase 4
- Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in EthiopiaActive, not recruitingNCT06586983
- Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)CompletedNCT06583161
- LIver FRAilty Management IN Cirrhosis (LIFRAMIN)CompletedNCT06573229Not applicable
- Role of ICCO Score in Predicting Outcome in ICU PatientsCompletedNCT06561477
- EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin SubstitutionCompletedNCT06544161Not applicable
- A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.CompletedNCT06525311Phase 1
- Effect of a GnRH Analog on Hepatic SteatosisActive, not recruitingNCT06523530Phase 4
- Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB StudyCompletedNCT06469489
- Comparison of Chitosan, Ankaferd and Tranexamic Acid in Dental Extraction in Liver Pre-Transplant ChildrenCompletedNCT06457360Early Phase 1
- Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal BleedingCompletedNCT06437964Not applicable
- The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in ChinaCompletedNCT06420791
- Proton Pump Inhibitors in Cirrhotic PatientsCompletedNCT06384443
- Study in Patients With Decompensated Liver CirrhosisActive, not recruitingNCT06380335
- Screening for Chronic Liver Diseases in General PopulationActive, not recruitingNCT06366425Not applicable
- A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With HypoalbuminemiaCompletedNCT06355479Phase 3
- The Association Between Albumin Administration and Short-term Rebleeding Risk in Cirrhosis Patients With Acute Variceal Hemorrhage and Stable HemodynamicsActive, not recruitingNCT06348004
- DIAbetes and NAFLDActive, not recruitingNCT06315361
- Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High RiskActive, not recruitingNCT06312826Not applicable
- Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.CompletedNCT06267794Phase 2
- Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker AnalysisCompletedNCT06262165
- Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal SyndromeActive, not recruitingNCT06256432Phase 2
- Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorsCompletedNCT06244550Not applicable
- Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal DiseaseCompletedNCT06161766
- Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLDStatus unknownNCT06144437
- A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)CompletedNCT06144086Phase 2
- Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver DiseaseActive, not recruitingNCT06136221Not applicable
- Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and AscitesCompletedNCT06091345Not applicable
- Prevalence of Pain in Hospitalized Cirrhotic PatientsCompletedNCT06062108
- Effects of Platelet Mimicking Nanoparticles in Patients With CirrhosisCompletedNCT06050993
- EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver DiseaseCompletedNCT06047327Not applicable
- Timing of Endoscopy in Cirrhotic Patients With Acute Variceal BleedingActive, not recruitingNCT06031402Not applicable
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMActive, not recruitingNCT06005012Phase 2
- SGLT-2 Inhibitors in the Treatment of AscitesActive, not recruitingNCT05999773
- Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic PatientsCompletedNCT05989789Not applicable
- A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in CirrhosisActive, not recruitingNCT05979935
- Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCCCompletedNCT05971108Phase 4
- A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver CirrhosisCompletedNCT05960006
- Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver FibrosisCompletedNCT05943899
- A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild CirrhosisCompletedNCT05939947Phase 1
- Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).CompletedNCT05937048Not applicable
- Early Liver Disease Breath DetectionCompletedNCT05935488